SO
79
4
DE
36
4
CFG
44
18
NAVI
32
-9
SHW
59
13
EOG
41
4
BDX
54
7
PEP
50
2
QCOM
80
9
AIG
56
2
SCHW
58
2
M
48
6
TMO
60
-3
ECL
84
2
HSY
53
2
STI
58
20
NOC
43
-5
SYY
50
2
ZION
55
3
CI
52
-14
SO
79
4
DE
36
4
CFG
44
18
NAVI
32
-9
SHW
59
13
EOG
41
4
BDX
54
7
PEP
50
2
QCOM
80
9
AIG
56
2
SCHW
58
2
M
48
6
TMO
60
-3
ECL
84
2
HSY
53
2
STI
58
20
NOC
43
-5
SYY
50
2
ZION
55
3
CI
52
-14
Financhill
Back

Seres Therapeutics Vs. Nuwellis Industry Stock Comparison

Buy
55

MCRB
Seres Therapeutics

Last Price:
1.10
Seasonality Move:
-20.76%
Sell
15

NUWE
Nuwellis

Last Price:
0.21
Seasonality Move:
-7.26%
Buy
55
Seres Therapeutics (MCRB) is a Buy

Is Seres Therapeutics a Buy, Sell or Hold?

  • The current Seres Therapeutics [MCRB] share price is $1.11. The Score for MCRB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • MCRB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
15
Nuwellis (NUWE) is a Sell

Is Nuwellis a Buy, Sell or Hold?

  • The current Nuwellis [NUWE] share price is $0.21. The Score for NUWE is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • NUWE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MCRB Stock Price Chart

What is Seres Therapeutics's stock price today?

  • The Seres Therapeutics share price today is $1.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MCRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

NUWE Stock Price Chart

What is Nuwellis's stock price today?

  • The Nuwellis share price today is $0.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUWE is experiencing slight buying pressure.

MCRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 74.4 Buy
Chaikin Money Flow: 3228380 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.89) Buy
Bollinger Bands (100): (0.78 - 1.24) Buy

NUWE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 39.86 Sell
Chaikin Money Flow: 11334061 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.23 - 0.39) Sell
Bollinger Bands (100): (0.35 - 0.59) Sell

MCRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.89 Buy
20-day SMA: 0.75 Buy
50-day SMA: 0.84 Buy
200-day SMA: 1.77 Sell
8-day EMA: 0.92 Buy
20-day EMA: 0.82 Buy
50-day EMA: 0.86 Buy
200-day EMA: 1.88 Sell

NUWE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.21 Buy
20-day SMA: 0.29 Sell
50-day SMA: 0.4 Sell
200-day SMA: 0.93 Sell
8-day EMA: 0.2 Buy
20-day EMA: 0.27 Sell
50-day EMA: 0.37 Sell
200-day EMA: 3.97 Sell

Seres Therapeutics Earnings Growth & MCRB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.30 per share.

Nuwellis Earnings Growth & NUWE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $6.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.10 per share, and a decrease next year of $0.00 per share.

Seres Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nuwellis Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):